Immix Biopharma Inc’s filing revealed that its Director Hsu Jason acquired Company’s shares for reported $0.14 million on Dec 11 ’23. In the deal valued at $4.67 per share,31,000 shares were bought. As a result of this transaction, Hsu Jason now holds 813,000 shares worth roughly $2.09 million.
Then, Hsu Jason bought 25,000 shares, generating $122,025 in total proceeds. Upon buying the shares at $4.88, the Director now owns 782,000 shares.
Before that, Hsu Jason bought 7,000 shares. Immix Biopharma Inc shares valued at $17,396 were divested by the Director at a price of $2.49 per share. As a result of the transaction, Hsu Jason now holds 757,000 shares, worth roughly $1.95 million.
Price Performance Review of IMMX
On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock fall -3.38% to $2.57. Over the last five days, the stock has lost -9.51%. Immix Biopharma Inc shares have fallen nearly -62.86% since the year began. Nevertheless, the stocks have risen 42.64% over the past one year. While a 52-week high of $7.75 was reached on 01/02/24, a 52-week low of $1.40 was recorded on 02/06/24. SMA at 50 days reached $3.03, while 200 days put it at $3.53. A total of 0.24 million shares were traded, compared to the trading of 95300.0 shares in the previous session.
Levels Of Support And Resistance For IMMX Stock
The 24-hour chart illustrates a support level at 2.50, which if violated will result in even more drops to 2.44. On the upside, there is a resistance level at 2.66. A further resistance level may holdings at 2.75. The Relative Strength Index (RSI) on the 14-day chart is 36.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.62%. Stochastics %K at 11.55% indicates the stock is a buying.
